Eicosanoids derived from cytochrome P450 pathway of arachidonic acid and inflammatory shock. 2019

Bahar Tunctan, and Sefika Pinar Senol, and Meryem Temiz-Resitoglu, and Demet Sinem Guden, and Seyhan Sahan-Firat, and John R Falck, and Kafait U Malik
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey. Electronic address: bunctan@gmail.com.

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock, the most common form of vasodilatory shock, is a subset of sepsis in which circulatory and cellular/metabolic abnormalities are severe enough to increase mortality. Inflammatory shock constitutes the hallmark of sepsis, but also a final common pathway of any form of severe long-term tissue hypoperfusion. The pathogenesis of inflammatory shock seems to be due to circulating substances released by pathogens (e.g., bacterial endotoxins) and host immuno-inflammatory responses (e.g., changes in the production of histamine, bradykinin, serotonin, nitric oxide [NO], reactive nitrogen and oxygen species, and arachidonic acid [AA]-derived eicosanoids mainly through NO synthase, cyclooxygenase, and cytochrome P450 [CYP] pathways, and proinflammatory cytokine formation). Therefore, refractory hypotension to vasoconstrictors with end-organ hypoperfusion is a life threatening feature of inflammatory shock. This review summarizes the current knowledge regarding the role of eicosanoids derived from CYP pathway of AA in animal models of inflammatory shock syndromes with an emphasis on septic shock in addition to potential therapeutic strategies targeting specific CYP isoforms responsible for proinflammatory/anti-inflammatory mediator production.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012769 Shock A pathological condition manifested by failure to perfuse or oxygenate vital organs. Circulatory Collapse,Circulatory Failure,Hypovolemic Shock,Collapse, Circulatory,Failure, Circulatory,Shock, Hypovolemic
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D016718 Arachidonic Acid An unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes, and leukotrienes. (all-Z)-5,8,11,14-Eicosatetraenoic acid,Arachidonic Acid, (all-Z)-Isomer, 1-(14)C-Labeled,Arachidonic Acid, (all-Z)-isomer, 3H-Labeled,Arachidonic Acid, Ammonium Salt, (all-Z)-Isomer,Arachidonic Acid, Cerium Salt, (all-Z)-Isomer,Arachidonic Acid, Cesium Salt, (all-Z)-Isomer,Arachidonic Acid, Lithium Salt, (all-Z)-Isomer,Arachidonic Acid, Potassium Salt, (all-Z)-Isomer,Arachidonic Acid, Sodium Salt,Arachidonic Acid, Sodium Salt, (all-Z)-Isomer,Arachidonic Acid, Zinc Salt, (all-Z)-Isomer,Sodium Arachidonate,Vitamin F,Arachidonate, Sodium
D018836 Inflammation Mediators The endogenous compounds that mediate inflammation (AUTACOIDS) and related exogenous compounds including the synthetic prostaglandins (PROSTAGLANDINS, SYNTHETIC). Mediators of Inflammation,Mediators, Inflammation
D019001 Nitric Oxide Synthase An NADPH-dependent enzyme that catalyzes the conversion of L-ARGININE and OXYGEN to produce CITRULLINE and NITRIC OXIDE. NO Synthase,Nitric-Oxide Synthase,Nitric-Oxide Synthetase,Nitric Oxide Synthetase,Oxide Synthase, Nitric,Synthase, Nitric Oxide

Related Publications

Bahar Tunctan, and Sefika Pinar Senol, and Meryem Temiz-Resitoglu, and Demet Sinem Guden, and Seyhan Sahan-Firat, and John R Falck, and Kafait U Malik
April 2009, Journal of lipid research,
Bahar Tunctan, and Sefika Pinar Senol, and Meryem Temiz-Resitoglu, and Demet Sinem Guden, and Seyhan Sahan-Firat, and John R Falck, and Kafait U Malik
August 1999, Science (New York, N.Y.),
Bahar Tunctan, and Sefika Pinar Senol, and Meryem Temiz-Resitoglu, and Demet Sinem Guden, and Seyhan Sahan-Firat, and John R Falck, and Kafait U Malik
December 2010, Cancer metastasis reviews,
Bahar Tunctan, and Sefika Pinar Senol, and Meryem Temiz-Resitoglu, and Demet Sinem Guden, and Seyhan Sahan-Firat, and John R Falck, and Kafait U Malik
November 2017, Pharmacology & therapeutics,
Bahar Tunctan, and Sefika Pinar Senol, and Meryem Temiz-Resitoglu, and Demet Sinem Guden, and Seyhan Sahan-Firat, and John R Falck, and Kafait U Malik
January 2016, Prostaglandins & other lipid mediators,
Bahar Tunctan, and Sefika Pinar Senol, and Meryem Temiz-Resitoglu, and Demet Sinem Guden, and Seyhan Sahan-Firat, and John R Falck, and Kafait U Malik
January 2007, Prostaglandins & other lipid mediators,
Bahar Tunctan, and Sefika Pinar Senol, and Meryem Temiz-Resitoglu, and Demet Sinem Guden, and Seyhan Sahan-Firat, and John R Falck, and Kafait U Malik
August 2015, Journal of the American Society of Nephrology : JASN,
Bahar Tunctan, and Sefika Pinar Senol, and Meryem Temiz-Resitoglu, and Demet Sinem Guden, and Seyhan Sahan-Firat, and John R Falck, and Kafait U Malik
April 2020, Prostaglandins & other lipid mediators,
Bahar Tunctan, and Sefika Pinar Senol, and Meryem Temiz-Resitoglu, and Demet Sinem Guden, and Seyhan Sahan-Firat, and John R Falck, and Kafait U Malik
April 2000, Trends in pharmacological sciences,
Bahar Tunctan, and Sefika Pinar Senol, and Meryem Temiz-Resitoglu, and Demet Sinem Guden, and Seyhan Sahan-Firat, and John R Falck, and Kafait U Malik
January 1991, Advances in prostaglandin, thromboxane, and leukotriene research,
Copied contents to your clipboard!